Insomnia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

Increasing Prevalence of Insomnia Sparks Growth in Treatment Market, Offering Opportunities for Pharmaceutical Companies

Insomnia, a pervasive and debilitating condition affecting millions worldwide, continues to escalate as a pressing public health concern. Despite the availability of effective treatment options, approximately 25% of the adult population grapples with sleeping disorders, with 6-10% diagnosed specifically with insomnia. In response to this growing crisis, the global insomnia treatment market is poised for substantial expansion during the forecast period of 2024-2031.

OTC Medications and Innovations Drive Market Growth

The rising demand for Over-The-Counter (OTC) sleep aids, coupled with the aging population - with a projected 56% increase in those aged 60 and above by 2030 - underscores the urgency for accessible and effective insomnia therapeutics. OTC drugs, such as natrol melatonin and unisom sleep gel, are anticipated to dominate the market, representing a significant share of revenue through 2031. Moreover, ongoing research efforts by leading pharmaceutical companies focus on developing novel pharmacological treatments, exploring diverse categories including neurokinin1 receptor antagonists, 5-HT1A agonists, and corticotropin-releasing hormone antagonists.

Cognitive Behavioral Therapy and Emerging Markets Offer Promising Opportunities

In addition to pharmacological interventions, cognitive behavioral therapy for insomnia (CBT-I) emerges as a highly effective treatment modality, particularly for older adults. Furthermore, developing economies like China and India present lucrative markets for healthcare facilities and sleep aids, with substantial opportunities for expansion and market penetration. The presence of a sizable undiagnosed insomnia patient pool underscores the imperative for improved recognition, diagnosis, and treatment strategies.

Unlocking Opportunities in the Sleep-Health Economy

The burgeoning multi-billion dollar sleep-health economy reflects the escalating demand for sound sleep solutions. This trend not only offers lucrative market opportunities for pharmaceutical companies but also creates avenues for retailers, health service providers, and consumer-oriented businesses to contribute to addressing the global insomnia epidemic.

Competitive Analysis

Key players in the insomnia treatment market include:

Sunovion Pharmaceuticals, Inc.
Natrol, LLC
GlaxoSmithKline Plc.
Sanofi SA
Pfizer Inc.
Boehringer Ingelheim International GmbH
Mallinckrodt
PERNIX Therapeutics
Takeda Pharmaceutical Company Limited
Merck & Co. Inc.
Others.

Market Segmentation

By Drug Type

OTC Drugs
- OTC Sleep Aids
- OTC Sleep Supplements
Prescription Drugs

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
e commerce
Drug Stores
Others

By Region

North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa

1. Executive Summary

1.1. Global Insomnia Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Insomnia Treatment Market Outlook, 2018 - 2031

3.1. Global Insomnia Treatment Market Outlook, by Drug Type, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. OTC Drugs
    - 3.1.1.1.1. OTC Sleep Aids
    - 3.1.1.1.2. OTC Sleep Supplements
  - 3.1.1.2. Prescription Drugs
3.2. Global Insomnia Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospital Pharmacies
  - 3.2.1.2. Retail Pharmacies
  - 3.2.1.3. E-commerce
  - 3.2.1.4. Drug Stores
  - 3.2.1.5. Others
3.3. Global Insomnia Treatment Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Insomnia Treatment Market Outlook, 2018 - 2031

4.1. North America Insomnia Treatment Market Outlook, by Drug Type, Value (US$ Mn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. OTC Drugs
    - 4.1.1.1.1. OTC Sleep Aids
    - 4.1.1.1.2. OTC Sleep Supplements
  - 4.1.1.2. Prescription Drugs
4.2. North America Insomnia Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospital Pharmacies
  - 4.2.1.2. Retail Pharmacies
  - 4.2.1.3. E-commerce
  - 4.2.1.4. Drug Stores
  - 4.2.1.5. Others
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Insomnia Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 4.3.1.2. U.S. Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 4.3.1.3. Canada Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 4.3.1.4. Canada Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Insomnia Treatment Market Outlook, 2018 - 2031

5.1. Europe Insomnia Treatment Market Outlook, by Drug Type, Value (US$ Mn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. OTC Drugs
    - 5.1.1.1.1. OTC Sleep Aids
    - 5.1.1.1.2. OTC Sleep Supplements
  - 5.1.1.2. Prescription Drugs
5.2. Europe Insomnia Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospital Pharmacies
  - 5.2.1.2. Retail Pharmacies
  - 5.2.1.3. E-commerce
  - 5.2.1.4. Drug Stores
  - 5.2.1.5. Others
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Insomnia Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.2. Germany Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 5.3.1.3. U.K. Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.4. U.K. Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 5.3.1.5. France Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.6. France Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 5.3.1.7. Italy Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.8. Italy Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 5.3.1.9. Turkey Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.10. Turkey Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 5.3.1.11. Russia Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.12. Russia Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Insomnia Treatment Market Outlook, 2018 - 2031

6.1. Asia Pacific Insomnia Treatment Market Outlook, by Drug Type, Value (US$ Mn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. OTC Drugs
    - 6.1.1.1.1. OTC Sleep Aids
    - 6.1.1.1.2. OTC Sleep Supplements
  - 6.1.1.2. Prescription Drugs
6.2. Asia Pacific Insomnia Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospital Pharmacies
  - 6.2.1.2. Retail Pharmacies
  - 6.2.1.3. E-commerce
  - 6.2.1.4. Drug Stores
  - 6.2.1.5. Others
- 6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Insomnia Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.2. China Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 6.3.1.3. Japan Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.4. Japan Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 6.3.1.5. South Korea Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.6. South Korea Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 6.3.1.7. India Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.8. India Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Insomnia Treatment Market Outlook, 2018 - 2031

7.1. Latin America Insomnia Treatment Market Outlook, by Drug Type, Value (US$ Mn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. OTC Drugs
    - 7.1.1.1.1. OTC Sleep Aids
    - 7.1.1.1.2. OTC Sleep Supplements
  - 7.1.1.2. Prescription Drugs
7.2. Latin America Insomnia Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Hospital Pharmacies
  - 7.2.1.2. Retail Pharmacies
  - 7.2.1.3. E-commerce
  - 7.2.1.4. Drug Stores
  - 7.2.1.5. Others
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Insomnia Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 7.3.1.2. Brazil Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 7.3.1.3. Mexico Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 7.3.1.4. Mexico Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 7.3.1.5. Argentina Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 7.3.1.6. Argentina Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Insomnia Treatment Market Outlook, 2018 - 2031

8.1. Middle East & Africa Insomnia Treatment Market Outlook, by Drug Type, Value (US$ Mn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. OTC Drugs
    - 8.1.1.1.1. OTC Sleep Aids
    - 8.1.1.1.2. OTC Sleep Supplements
  - 8.1.1.2. Prescription Drugs
8.2. Middle East & Africa Insomnia Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospital Pharmacies
  - 8.2.1.2. Retail Pharmacies
  - 8.2.1.3. E-commerce
  - 8.2.1.4. Drug Stores
  - 8.2.1.5. Others
8.3. Middle East & Africa Insomnia Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.2. GCC Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 8.3.1.3. South Africa Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.4. South Africa Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 8.3.1.5. Egypt Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.6. Egypt Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 8.3.1.7. Nigeria Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.8. Nigeria Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa Insomnia Treatment Market by Drug Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Insomnia Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs by Distribution Channel Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Sunovion Pharmaceuticals, Inc.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Natrol, LLC
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. GlaxoSmithKline Plc.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Sanofi SA
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Pfizer Inc.
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Boehringer Ingelheim International GmbH
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Mallinckrodt
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. PERNIX Therapeutics
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Takeda Pharmaceutical Company Limited
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Merck & Co. Inc.
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development
  - 9.4.10.5. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations